Page last updated: 2024-08-17

floxuridine and benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone

floxuridine has been researched along with benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Denmeade, SR; Isaacs, JT; Lin, XS; Tombal, B1

Other Studies

1 other study(ies) available for floxuridine and benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone

ArticleYear
Inhibition of caspase activity does not prevent the signaling phase of apoptosis in prostate cancer cells.
    The Prostate, 1999, Jun-01, Volume: 39, Issue:4

    Topics: Amino Acid Chloromethyl Ketones; Animals; Antimetabolites, Antineoplastic; Apoptosis; Blotting, Western; Caspase Inhibitors; Cell Survival; Clone Cells; Cysteine Proteinase Inhibitors; Enzyme Inhibitors; Floxuridine; Humans; Male; Oligopeptides; Prostatic Neoplasms; Rats; Retinoblastoma Protein; Signal Transduction; Thapsigargin; Tumor Cells, Cultured

1999